Biomics Centre

Product candidates

The clinical trials performed by Biomics offer its participants the chance to become a part of their own healthcare and to have access to potential novel treatments and drugs before they are commercially available. Such studies offer a significant amount of information towards the advancement of medical care and are vital in terms of uncovering effective cures for type 1 and type 2 diabetes.

When a potentially efficient treatment or drug is developed in our labs and its safety is comprehensively tested in preclinical trials, researchers at Biomics begin conducting clinical trials in patients offering them first-rate care and associated study medicines throughout the duration of the trial with no expenses required on their part.

Type 1 diabetes candidate: Afremlin

Alongside a proper diet and a regular exercise program Afremlin is used to regulate blood sugar levels in individuals diagnosed with type 1 diabetes. Regulating increased sugar levels in the bloodstream helps with averting health risks associated with type 1 diabetes such as blindness, kidney failure, strokes and sexual dysfunctions.
Afremlin is a man manufactured product that is identical to the insulin produced by the human body, thus replacing the insulin that would be normally generated by the pancreas. Afremlin begins functioning faster and lasts longer than regular insulin, assisting glucose to access cells that use it for energy.

Type 2 diabetes candidate: Glucolitol RX

Glucolitol RX is used to regulate blood sugar levels in individuals diagnosed with type 2 diabetes.
It functions by helping the body reestablish its appropriate response to the insulin it normally produces, reducing the amount of sugar produced by the liver and absorbed by the stomach as well as the intestines.
Alongside a balanced diet and regular physical exercises, Glucolitol RX is also expected to prevent the onset of diabetes in individuals at risk of developing the diseases. Likewise it can also be used in women with polycystic ovaries, regulating menstrual cycles and increasing fecundity.

B.I.O – Biomics Insulin Organoid

 

The Biomics Insulin Organoid (B.I.O.) is an engineered micro-organ that functions in a similar manner to the human pancreas, containing real islets that can sense sugars in the bloodstream and dispense the appropriate amount of necessary insulin in real time.
For the myriad of individuals suffering from diabetes worldwide, the B.I.O. offers the unprecedented possibility of natural insulin production and normalized blood sugar levels.
More info
In the case of type 1 diabetes the body’s immune system erroneously eliminates the islet cells of the pancreas. Biomics endeavors to design an efficient biological cure by replacing the previously destroyed islets. Following separate clinical trials, researchers at Biomics have transplanted islet cells into individuals with enduring type 1 diabetes, the result of which was the lack of need for external insulin for the recipients of the treatment. Nonetheless this type of procedure has been limited so far only to the most serious cases of diabetes, with a number of obstacles still being needed to be overcome before such a treatment can be safely and confidently offered to those that need it the most.